KCNJ3 is a novel candidate gene for autosomal dominant pure hereditary spastic paraplegia identified using whole genome sequencing
American Journal of Medical Genetics Part B: Neuropsychiatric Genetics · 2024
DOI: 10.1002/ajmg.b.32984 ↗Kurz gefasst
Fachartikel in der Zeitschrift American Journal of Medical Genetics Part B: Neuropsychiatric Genetics, 2024. Verfasst von Woong-Woo Lee und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Nowon Eulji Medical Center, Eulji University School of Medicine, Seoul, Republic of Korea. Hauptthemen laut MEDLINE: Spastic Paraplegia, Hereditary, Whole Genome Sequencing, Pedigree. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Hereditary spastic paraplegia (HSP) is a group of familial diseases characterized by progressive corticospinal tract degeneration. Clinically, patients present with lower‐limb spasticity and weakness. To date, more than 80 genetic HSP types have been identified. Despite advances in molecular genetics, novel HSP gene discoveries are ongoing, with a low genetic diagnostic yield. In this study, we aimed to determine pathogenic variants in a family with HSP, which was not diagnosed through conventional genetic testing. We clinically characterized a large family and conducted whole genome sequencing (WGS) analysis of four affected and three unaffected individuals in the family to identify the genetic cause of HSP. This family had autosomal dominant pure (uncomplicated) late childhood‐onset HSP. The patients' symptoms accelerated between the ages of 20 and 30. Brain magnetic resonance images typically showed white matter changes, a thin corpus callosum, and cerebellar atrophy. We identified a heterozygous missense variant, KCNJ3 c.1297T>G (p.Leu433Val), through WGS and family genetic analysis, confirmed by Sanger sequencing. We suggest that the identification of KCNJ3 c.1297T>G (p.Leu433Val) constitutes the discovery of a potential novel gene responsible for HSP in this family. This is the first study to report the possible role of a KCNJ3 variant in HSP pathogenesis. Our findings further expand the phenotypic and genotypic spectrum of HSP.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Neurology, Nowon Eulji Medical Center, Eulji University School of Medicine, Seoul, Republic of Korea.
- Department of Pediatrics, Nowon Eulji Medical Center, Eulji University School of Medicine, Seoul, Republic of Korea.
- GC Genome, Yongin, Gyeonggi-do, Republic of Korea.
ORCID-Profile: Cha Gon Lee
Zitieren
APA
Lee, W. W., Lee, C. G., & Ki, C. S. (2024). KCNJ3 is a novel candidate gene for autosomal dominant pure hereditary spastic paraplegia identified using whole genome sequencing. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics. https://doi.org/10.1002/ajmg.b.32984
Vancouver
Lee WW, Lee CG, Ki CS. KCNJ3 is a novel candidate gene for autosomal dominant pure hereditary spastic paraplegia identified using whole genome sequencing. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics. 2024. doi:10.1002/ajmg.b.32984
BibTeX
@article{Lee2024,
author = {Lee, Woong-Woo and Lee, Cha Gon and Ki, Chang-Seok},
title = {KCNJ3 is a novel candidate gene for autosomal dominant pure hereditary spastic paraplegia identified using whole genome sequencing},
journal = {American Journal of Medical Genetics Part B: Neuropsychiatric Genetics},
year = {2024},
doi = {10.1002/ajmg.b.32984}
}
EUVIMED